Farletuzumab
Other name
-
International/Other brands
Not Available
Groups
Investigational
Structure
Prescription products
| Name | Dosage | Strength | Route | Labeller |
|---|---|---|---|---|
| No data available. | ||||
Target
FOLR1
Description
Farletuzumab (MORAb-003) is a fully humanized monoclonal antibody against the folate receptor alpha, for the potential treatment of epithelial ovarian cancer.
Indications
Investigated for use/treatment in ovarian cancer.
Other indications
-
Mechaism of action
-
Absorption
-
Metabolism
-
Toxicity
-